EPRX
Eupraxia Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.36
-0.14 ▼ -1.87%
🌙 3월 13일 7:30 PM ET (한국 3/14 08:30)
$7.50
+0.14 ▲ +1.90%
| Index | - | P/E | - | EPS (ttm) | -0.99 | Insider Own | 23.12% | Shs Outstand | 0.05B | Perf Week | -7.88% |
| Market Cap | 0.37B | Forward P/E | - | EPS next Y | 13.87% | Insider Trans | - | Shs Float | 0.04B | Perf Month | -13.31% |
| Enterprise Value | 0.32B | PEG | - | EPS next Q | -0.17 | Inst Own | 33.5% | Short Float | 5.08% | Perf Quarter | 16.83% |
| Income | -0.04B | P/S | - | EPS this Y | 30.21% | Inst Trans | 3.09% | Short Ratio | 9.29 | Perf Half Y | 34.55% |
| Sales | 0.00B | P/B | 7.31 | EPS next 5Y | 2.17% | ROA | -63.71% | Short Interest | 1.98M | Perf YTD | -2.52% |
| Book/sh | 1.01 | P/C | 4.63 | EPS past 3/5Y | -2.38% -34.75% | ROE | -66.83% | 52W High | -21.03% ($9.32) | Perf Year | 77.35% |
| Cash/sh | 1.59 | P/FCF | - | Sales past 3/5Y | - | ROIC | -50.06% | 52W Low | 174.62% ($2.68) | Perf 3Y | 145.33% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 5.48% | Gross Margin | - | Volatility(W/M) | 6.24% 5.16% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.43 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 15.12 | EPS Q/Q | -58.38% | Profit Margin | - | RSI (14) | 36.82 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 15.12 | Sales Q/Q | - | SMA20 | -8.52% ($8.05) | Beta | 1.76 | Target Price | $14.27 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -10.82% ($8.25) | Rel Volume | 0.52 | Prev Close | $7.5 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | -91.29% - | SMA200 | 18.27% ($6.22) | Avg Volume(3M) | 0.21M | Price | $7.36 |
| IPO | 2021/8/3 | Option/Short | No/Yes | Trades | 1009 | Volume | 110,699 | Change | -1.87% |
뉴스 로딩 중...